| 1 |
Roma-rodrigues C, Fernandes AR, Baptista PV. Exploring RAB11A Pathway to Hinder Chronic Myeloid Leukemia-Induced Angiogenesis In Vivo. Pharmaceutics 2023;15:742. [DOI: 10.3390/pharmaceutics15030742] [Reference Citation Analysis]
|
| 2 |
Desilets A, Soulières D. PI3K Inhibition for Squamous Cell Head and Neck Carcinoma. Cancer J 2022;28:369-76. [PMID: 36165725 DOI: 10.1097/PPO.0000000000000618] [Reference Citation Analysis]
|
| 3 |
Vieira ÉLM, Martins FMA, Bellozi PMQ, Gonçalves AP, Siqueira JM, Gianetti A, Teixeira AL, de Oliveira ACP. PI3K, mTOR and GSK3 modulate cytokines' production in peripheral leukocyte in temporal lobe epilepsy. Neurosci Lett 2021;756:135948. [PMID: 33979699 DOI: 10.1016/j.neulet.2021.135948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Doukas PG, Vageli DP, Sasaki CT, Judson BL. Pepsin Promotes Activation of Epidermal Growth Factor Receptor and Downstream Oncogenic Pathways, at Slightly Acidic and Neutral pH, in Exposed Hypopharyngeal Cells. Int J Mol Sci 2021;22:4275. [PMID: 33924087 DOI: 10.3390/ijms22084275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Catar R, Moll G, Hosp I, Simon M, Luecht C, Zhao H, Wu D, Chen L, Kamhieh-Milz J, Korybalska K, Zickler D, Witowski J. Transcriptional Regulation of Thrombin-Induced Endothelial VEGF Induction and Proangiogenic Response. Cells 2021;10:910. [PMID: 33920990 DOI: 10.3390/cells10040910] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 6 |
Le X, Nilsson M, Goldman J, Reck M, Nakagawa K, Kato T, Ares LP, Frimodt-moller B, Wolff K, Visseren-grul C, Heymach JV, Garon EB. Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC. Journal of Thoracic Oncology 2021;16:205-15. [DOI: 10.1016/j.jtho.2020.10.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 7 |
Chen Z, Viswanathan R, Morgan EL, Jeon J, Van Waes C. Proinflammatory Signaling Pathways and Genomic Signatures in Head and Neck Cancers. Early Detection and Treatment of Head & Neck Cancers 2021. [DOI: 10.1007/978-3-030-69852-2_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Aggarwal N, Yadav J, Thakur K, Bibban R, Chhokar A, Tripathi T, Bhat A, Singh T, Jadli M, Singh U, Kashyap MK, Bharti AC. Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns. Front Cell Infect Microbiol 2020;10:537650. [PMID: 33344262 DOI: 10.3389/fcimb.2020.537650] [Reference Citation Analysis]
|
| 9 |
Aggarwal N, Yadav J, Thakur K, Bibban R, Chhokar A, Tripathi T, Bhat A, Singh T, Jadli M, Singh U, Kashyap MK, Bharti AC. Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns. Front Cell Infect Microbiol 2020;10:537650. [PMID: 33344262 DOI: 10.3389/fcimb.2020.537650] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 10 |
Huang MY, Jiang XM, Wang BL, Sun Y, Lu JJ. Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms. Pharmacol Ther 2021;219:107694. [PMID: 32980443 DOI: 10.1016/j.pharmthera.2020.107694] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 11 |
Rai V, Aggarwal SK, Verma SS, Awasthee N, Dhasmana A, Aggarwal S, Das SN, Nair MS, Yadav S, Gupta SC. Epoxyazadiradione exhibit activities in head and neck squamous cell carcinoma by targeting multiple pathways. Apoptosis 2020;25:763-82. [PMID: 32894380 DOI: 10.1007/s10495-020-01633-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Reck M, Shankar G, Lee A, Coleman S, McCleland M, Papadimitrakopoulou VA, Socinski MA, Sandler A. Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations. Expert Rev Respir Med 2020;14:125-36. [PMID: 31829747 DOI: 10.1080/17476348.2020.1701439] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 13 |
Wilson TG, Hanna A, Recknagel J, Pruetz BL, Baschnagel AM, Wilson GD. Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation. Head Neck 2020;42:153-62. [PMID: 31657099 DOI: 10.1002/hed.25983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Yadav V, Krishnan A, Vohora D. A systematic review on Piper longum L.: Bridging traditional knowledge and pharmacological evidence for future translational research. J Ethnopharmacol 2020;247:112255. [PMID: 31568819 DOI: 10.1016/j.jep.2019.112255] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 15 |
Della Corte CM, Barra G, Ciaramella V, Di Liello R, Vicidomini G, Zappavigna S, Luce A, Abate M, Fiorelli A, Caraglia M, Santini M, Martinelli E, Troiani T, Ciardiello F, Morgillo F. Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures. J Exp Clin Cancer Res 2019;38:253. [PMID: 31196138 DOI: 10.1186/s13046-019-1257-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 16 |
Chen DS, Hurwitz H. Combinations of Bevacizumab With Cancer Immunotherapy. Cancer J. 2018;24:193-204. [PMID: 30119083 DOI: 10.1097/ppo.0000000000000327] [Cited by in Crossref: 104] [Cited by in F6Publishing: 109] [Article Influence: 26.0] [Reference Citation Analysis]
|
| 17 |
Reck M, Mok TSK, Nishio M, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Lee A, Coleman S, Deng Y, Kowanetz M, Shankar G, Lin W, Socinski MA; IMpower150 Study Group. Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial. Lancet Respir Med 2019;7:387-401. [PMID: 30922878 DOI: 10.1016/S2213-2600(19)30084-0] [Cited by in Crossref: 432] [Cited by in F6Publishing: 413] [Article Influence: 108.0] [Reference Citation Analysis]
|
| 18 |
Zamudio-Cuevas Y, Fernández-Torres J, Martínez-Nava GA, Martínez-Flores K, Ramírez Olvera A, Medina-Luna D, Hernández Pérez AD, Landa-Solís C, López-Reyes A. Phagocytosis of monosodium urate crystals by human synoviocytes induces inflammation. Exp Biol Med (Maywood) 2019;244:344-51. [PMID: 30739483 DOI: 10.1177/1535370219830665] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 19 |
Tanriverdi O, Yilmaz İ, Adilay HU, Gunaldi O, Erdogan U, Gungor A, Kilic M, Tanik C. Effect of Cetuximab on the Development of Epidural Fibrosis Based on CD105 and Osteopontin Immunohistochemical Staining. Spine (Phila Pa 1976) 2019;44:E134-43. [PMID: 30015719 DOI: 10.1097/BRS.0000000000002793] [Reference Citation Analysis]
|
| 20 |
Pan C, Issaeva N, Yarbrough WG. HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis. Cancers Head Neck 2018;3:12. [PMID: 31093365 DOI: 10.1186/s41199-018-0039-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 21 |
Zhu X, Liu M, Lv J, Guo L, Li C, Dong L, Liu B. Good local tumor control but lethal hemorrhage after apatinib treatment for intractable squamous carcinoma of the floor of the mouth: a case report. Onco Targets Ther 2018;11:8909-13. [PMID: 30573977 DOI: 10.2147/OTT.S180358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 22 |
Sapna G, Gokul S. Next generation sequencing in oral disease diagnostics. World J Stomatol 2018; 6(2): 6-10 [DOI: 10.5321/wjs.v6.i2.6] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 23 |
Tampa M, Mitran MI, Mitran CI, Sarbu MI, Matei C, Nicolae I, Caruntu A, Tocut SM, Popa MI, Caruntu C, Georgescu SR. Mediators of Inflammation - A Potential Source of Biomarkers in Oral Squamous Cell Carcinoma. J Immunol Res 2018;2018:1061780. [PMID: 30539028 DOI: 10.1155/2018/1061780] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 24 |
Vivacqua A, Sebastiani A, Miglietta AM, Rigiracciolo DC, Cirillo F, Galli GR, Talia M, Santolla MF, Lappano R, Giordano F, Panno ML, Maggiolini M. miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs). Cells 2018;7:E203. [PMID: 30423928 DOI: 10.3390/cells7110203] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 25 |
Blas K, Wilson TG, Tonlaar N, Galoforo S, Hana A, Marples B, Wilson GD. Dual blockade of PI3K and MEK in combination with radiation in head and neck cancer. Clin Transl Radiat Oncol 2018;11:1-10. [PMID: 30014041 DOI: 10.1016/j.ctro.2018.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 26 |
Singh M, Yadav S, Kumar M, Saxena S, Saraswat D, Bansal A, Singh SB. The MAPK-activator protein-1 signaling regulates changes in lung tissue of rat exposed to hypobaric hypoxia. J Cell Physiol 2018;233:6851-65. [PMID: 29665093 DOI: 10.1002/jcp.26556] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 27 |
Krishna A, Bhatt MLB, Singh V, Singh S, Gangwar PK, Singh US, Kumar V, Mehrotra D. Differential Expression of c-fos Proto-Oncogene in Normal Oral Mucosa versus Squamous Cell Carcinoma. Asian Pac J Cancer Prev 2018;19:867-74. [PMID: 29582647 DOI: 10.22034/APJCP.2018.19.3.867] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
|
| 28 |
Wang S, Lu J, You Q, Huang H, Chen Y, Liu K. The mTOR/AP-1/VEGF signaling pathway regulates vascular endothelial cell growth. Oncotarget 2016;7:53269-76. [PMID: 27458160 DOI: 10.18632/oncotarget.10756] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 29 |
Wu D, Cheng J, Sun G, Wu S, Li M, Gao Z, Zhai S, Li P, Su D, Wang X. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma. Oncotarget 2016;7:36539-50. [PMID: 27174914 DOI: 10.18632/oncotarget.9282] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 30 |
Van Waes C, Musbahi O. Genomics and advances towards precision medicine for head and neck squamous cell carcinoma. Laryngoscope Investig Otolaryngol 2017;2:310-9. [PMID: 29094075 DOI: 10.1002/lio2.86] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 31 |
Tonlaar N, Galoforo S, Thibodeau BJ, Ahmed S, Wilson TG, Yumpo Cardenas P, Marples B, Wilson GD. Antitumor activity of the dual PI3K/MTOR inhibitor, PF-04691502, in combination with radiation in head and neck cancer. Radiother Oncol 2017;124:504-12. [PMID: 28823407 DOI: 10.1016/j.radonc.2017.08.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 32 |
Chan LP, Liu C, Chiang FY, Wang LF, Lee KW, Chen WT, Kuo PL, Liang CH. IL-8 promotes inflammatory mediators and stimulates activation of p38 MAPK/ERK-NF-κB pathway and reduction of JNK in HNSCC. Oncotarget 2017;8:56375-88. [PMID: 28915597 DOI: 10.18632/oncotarget.16914] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 33 |
Chen Y, Zhao R, Zhao Q, Shao Y, Zhang S. Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway. Oncol Res 2016;24:153-60. [PMID: 27458096 DOI: 10.3727/096504016X14612603423476] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 34 |
Cash H, Shah S, Moore E, Caruso A, Uppaluri R, Van Waes C, Allen C. mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer. Oncotarget 2015;6:36400-17. [PMID: 26506415 DOI: 10.18632/oncotarget.5063] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 35 |
Jiang C, Zhu Y, Zhou Z, Gumin J, Bengtsson L, Wu W, Songyang Z, Lang FF, Lin X. TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression. Oncogene 2017;36:2813-23. [DOI: 10.1038/onc.2016.430] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 36 |
Hung MS, Chen IC, Lin PY, Lung JH, Li YC, Lin YC, Yang CT, Tsai YH. Epidermal growth factor receptor mutation enhances expression of vascular endothelial growth factor in lung cancer. Oncol Lett 2016;12:4598-604. [PMID: 28101216 DOI: 10.3892/ol.2016.5287] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 37 |
Lin Y, Mallen-St Clair J, Wang G, Luo J, Palma-Diaz F, Lai C, Elashoff DA, Sharma S, Dubinett SM, St John M. p38 MAPK mediates epithelial-mesenchymal transition by regulating p38IP and Snail in head and neck squamous cell carcinoma. Oral Oncol 2016;60:81-9. [PMID: 27531877 DOI: 10.1016/j.oraloncology.2016.06.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 38 |
Hung MS, Chen IC, Lung JH, Lin PY, Li YC, Tsai YH. Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells. PLoS One 2016;11:e0158395. [PMID: 27362942 DOI: 10.1371/journal.pone.0158395] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 39 |
Chang WC, Wu SL, Huang WC, Hsu JY, Chan SH, Wang JM, Tsai JP, Chen BK. PTX3 gene activation in EGF-induced head and neck cancer cell metastasis. Oncotarget 2015;6:7741-57. [PMID: 25797258 DOI: 10.18632/oncotarget.3482] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 40 |
Ruiz EJ, Oeztuerk-Winder F, Ventura JJ. A paracrine network regulates the cross-talk between human lung stem cells and the stroma. Nat Commun 2014;5:3175. [PMID: 24430801 DOI: 10.1038/ncomms4175] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 41 |
Chang I, Rehman AO, Wang C. Molecular Signaling in Oral Cancer Invasion and Metastasis. Targeting Oral Cancer 2016. [DOI: 10.1007/978-3-319-27647-2_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 42 |
Kansy BA, Lee SC, Ferris RL. Immunology of Head and Neck Cancer. Head and Neck Cancer 2016. [DOI: 10.1007/978-3-319-27601-4_6] [Reference Citation Analysis]
|
| 43 |
Sass S, Pitea A, Unger K, Hess J, Mueller NS, Theis FJ. MicroRNA-Target Network Inference and Local Network Enrichment Analysis Identify Two microRNA Clusters with Distinct Functions in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2015;16:30204-22. [PMID: 26694379 DOI: 10.3390/ijms161226230] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 44 |
Lee EY, Kang JY, Kim KW. Expression of cyclooxygenase-2, peroxiredoxin I, peroxiredoxin 6 and nuclear factor-κB in oral squamous cell carcinoma. Oncol Lett 2015;10:3129-36. [PMID: 26722300 DOI: 10.3892/ol.2015.3705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 45 |
Rao VH, Rai V, Stoupa S, Agrawal DK. Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells. Am J Physiol Heart Circ Physiol 2015;309:H1075-86. [PMID: 26254334 DOI: 10.1152/ajpheart.00378.2015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 46 |
Perri A, Vizza D, Lupinacci S, Toteda G, De Amicis F, Leone F, Gigliotti P, Lofaro D, La Russa A, Bonofiglio R. Adiponectin secreted by tubular renal cells during LPS exposure worsens the cellular inflammatory damage. J Nephrol 2016;29:185-94. [PMID: 26215580 DOI: 10.1007/s40620-015-0220-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 47 |
Yoo YH, Kim YR, Kim MS, Lee KJ, Park KH, Hahn JH. YAC tripeptide of epidermal growth factor promotes the proliferation of HaCaT keratinocytes through activation of EGFR. BMB Rep 2014;47:581-6. [PMID: 25179402 DOI: 10.5483/bmbrep.2014.47.10.151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 48 |
Gaykalova DA, Manola JB, Ozawa H, Zizkova V, Morton K, Bishop JA, Sharma R, Zhang C, Michailidi C, Considine M, Tan M, Fertig EJ, Hennessey PT, Ahn J, Koch WM, Westra WH, Khan Z, Chung CH, Ochs MF, Califano JA. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma. Int J Cancer 2015;137:1879-89. [PMID: 25857630 DOI: 10.1002/ijc.29558] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 49 |
Mohan S, Vander Broek R, Shah S, Eytan DF, Pierce ML, Carlson SG, Coupar JF, Zhang J, Cheng H, Chen Z, Van Waes C. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2015;21:3946-56. [PMID: 25977343 DOI: 10.1158/1078-0432.CCR-14-3377] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 50 |
Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015;517:576-82. [PMID: 25631445 DOI: 10.1038/nature14129] [Cited by in Crossref: 2499] [Cited by in F6Publishing: 2589] [Article Influence: 312.4] [Reference Citation Analysis]
|
| 51 |
Bian Y, Han J, Kannabiran V, Mohan S, Cheng H, Friedman J, Zhang L, VanWaes C, Chen Z. MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer. Int J Biol Sci 2015;11:411-22. [PMID: 25798061 DOI: 10.7150/ijbs.10745] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 52 |
Li F, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS, Sethi G. NF-κB in cancer therapy. Arch Toxicol 2015;89:711-31. [PMID: 25690730 DOI: 10.1007/s00204-015-1470-4] [Cited by in Crossref: 135] [Cited by in F6Publishing: 144] [Article Influence: 16.9] [Reference Citation Analysis]
|
| 53 |
St John MA. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma. Laryngoscope 2015;125 Suppl 3:S1-11. [PMID: 25646683 DOI: 10.1002/lary.24998] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 54 |
Fang CY, Wu CC, Hsu HY, Chuang HY, Huang SY, Tsai CH, Chang Y, Tsao GS, Chen CL, Chen JY. EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells. Int J Mol Sci 2015;16:2530-58. [PMID: 25625511 DOI: 10.3390/ijms16022530] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 55 |
Van Waes C. Role of Free Radicals in Head and Neck Cancer. Free Radicals in ENT Pathology 2015. [DOI: 10.1007/978-3-319-13473-4_22] [Reference Citation Analysis]
|
| 56 |
Jiang C, Lin X. Analysis of epidermal growth factor-induced NF-κB signaling. Methods Mol Biol 2015;1280:75-102. [PMID: 25736745 DOI: 10.1007/978-1-4939-2422-6_6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 57 |
Lee MK, Kim IH, Choi YH, Nam TJ. A peptide from Porphyra yezoensis stimulates the proliferation of IEC-6 cells by activating the insulin-like growth factor I receptor signaling pathway. Int J Mol Med 2015;35:533-8. [PMID: 25500890 DOI: 10.3892/ijmm.2014.2037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 58 |
Tabatabaeifar S, Kruse TA, Thomassen M, Larsen MJ, Sørensen JA. Use of next generation sequencing in head and neck squamous cell carcinomas: a review. Oral Oncol 2014;50:1035-40. [PMID: 25223596 DOI: 10.1016/j.oraloncology.2014.08.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 59 |
D'Amato V, Rosa R, D'Amato C, Formisano L, Marciano R, Nappi L, Raimondo L, Di Mauro C, Servetto A, Fusciello C, Veneziani BM, De Placido S, Bianco R. The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models. Br J Cancer 2014;110:2887-95. [PMID: 24823695 DOI: 10.1038/bjc.2014.241] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 60 |
Wang J, Taylor A, Showeil R, Trivedi P, Horimoto Y, Bagwan I, Ewington L, Lam EW, El-Bahrawy MA. Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma. Cytokine 2014;68:94-100. [PMID: 24845798 DOI: 10.1016/j.cyto.2014.04.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 61 |
Li X, Xu Q, Wu Y, Li J, Tang D, Han L, Fan Q. A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma. Carcinogenesis 2014;35:1362-70. [DOI: 10.1093/carcin/bgu046] [Cited by in Crossref: 45] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 62 |
Vander Broek R, Mohan S, Eytan D, Chen Z, Van Waes C. The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies. Oral Dis 2015;21:815-25. [DOI: 10.1111/odi.12206] [Cited by in Crossref: 89] [Cited by in F6Publishing: 105] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 63 |
Vander Broek R, Snow GE, Chen Z, Van Waes C. Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling. Oral Oncol 2014;50:930-41. [PMID: 24177052 DOI: 10.1016/j.oraloncology.2013.10.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 64 |
Ginzburg S, Golovine KV, Makhov PB, Uzzo RG, Kutikov A, Kolenko VM. Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells. Prostate 2014;74:177-86. [PMID: 24151226 DOI: 10.1002/pros.22739] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 65 |
Yan B, Li H, Yang X, Shao J, Jang M, Guan D, Zou S, Van Waes C, Chen Z, Zhan M. Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma. PLoS One 2013;8:e73656. [PMID: 24069219 DOI: 10.1371/journal.pone.0073656] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 66 |
Friedman JA, Wise SC, Hu M, Gouveia C, Vander Broek R, Freudlsperger C, Kannabiran VR, Arun P, Mitchell JB, Chen Z, Van Waes C. HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma. Transl Oncol 2013;6:429-41. [PMID: 23908686 DOI: 10.1593/tlo.13292] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 67 |
Shionome T, Endo S, Omagari D, Asano M, Toyoma H, Ishigami T, Komiyama K. Nickel ion inhibits nuclear factor-kappa B activity in human oral squamous cell carcinoma. PLoS One 2013;8:e68257. [PMID: 23844176 DOI: 10.1371/journal.pone.0068257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 68 |
Herzog A, Bian Y, Vander Broek R, Hall B, Coupar J, Cheng H, Sowers AL, Cook JD, Mitchell JB, Chen Z, Kulkarni AB, Van Waes C. PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer. Clin Cancer Res 2013;19:3808-19. [PMID: 23640975 DOI: 10.1158/1078-0432.CCR-12-2716] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 69 |
Lui VW, Hedberg ML, Li H, Vangara BS, Pendleton K, Zeng Y, Lu Y, Zhang Q, Du Y, Gilbert BR. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013;3:761-769. [PMID: 23619167 DOI: 10.1158/2159-8290.cd-13-0103] [Cited by in Crossref: 422] [Cited by in F6Publishing: 444] [Article Influence: 42.2] [Reference Citation Analysis]
|
| 70 |
Lee K, Shin J, Kwon Y, Moon D, Nam K. Suppression of cancer progression and metastasis in HT-29 human colorectal adenocarcinomas by deep sea water. Biotechnol Bioproc E 2013;18:194-200. [DOI: 10.1007/s12257-012-0543-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 71 |
Ko SC, Huang CR, Shieh JM, Yang JH, Chang WC, Chen BK. Epidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1β expression. PLoS One 2013;8:e55795. [PMID: 23383347 DOI: 10.1371/journal.pone.0055795] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 72 |
Lenarduzzi M, Hui AB, Alajez NM, Shi W, Williams J, Yue S, O'Sullivan B, Liu FF. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. PLoS One 2013;8:e53765. [PMID: 23335975 DOI: 10.1371/journal.pone.0053765] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 73 |
Yan B, Broek RV, Saleh AD, Mehta A, Van Waes C, Chen Z. Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer. J Carcinog Mutagen 2013;Suppl 7:4. [PMID: 25587491 DOI: 10.4172/2157-2518.S7-004] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 74 |
Tsai P, Hsieh C, Chiu C, Wang C, Chang L, Lin S. Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway. Toxicon 2012;60:734-43. [DOI: 10.1016/j.toxicon.2012.05.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 75 |
Sheikh AQ, Taghian T, Hemingway B, Cho H, Kogan AB, Narmoneva DA. Regulation of endothelial MAPK/ERK signalling and capillary morphogenesis by low-amplitude electric field. J R Soc Interface 2013;10:20120548. [PMID: 22993248 DOI: 10.1098/rsif.2012.0548] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 76 |
Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, Chen Z, Van Waes C. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene 2013;32:1549-59. [PMID: 22641218 DOI: 10.1038/onc.2012.171] [Cited by in Crossref: 167] [Cited by in F6Publishing: 182] [Article Influence: 15.2] [Reference Citation Analysis]
|
| 77 |
Jouan-hureaux V, Boura C, Merlin J, Faivre B. Modulation of endothelial cell network formation in vitro by molecular signaling of head and neck squamous cell carcinoma (HNSCC) exposed to cetuximab. Microvascular Research 2012;83:131-7. [DOI: 10.1016/j.mvr.2011.07.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 78 |
Takahashi O, Komaki R, Smith PD, Jürgensmeier JM, Ryan A, Bekele BN, Wistuba II, Jacoby JJ, Korshunova MV, Biernacka A, Erez B, Hosho K, Herbst RS, O'Reilly MS. Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis. Clin Cancer Res 2012;18:1641-54. [PMID: 22275507 DOI: 10.1158/1078-0432.CCR-11-2324] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 79 |
Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK. Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16:15-31. [PMID: 22239438 DOI: 10.1517/14728222.2011.648617] [Cited by in Crossref: 533] [Cited by in F6Publishing: 562] [Article Influence: 48.5] [Reference Citation Analysis]
|
| 80 |
Mendelsohn AH, Lai CK, Shintaku IP, Fishbein MC, Brugman K, Elashoff DA, Abemayor E, Dubinett SM, St John MA. Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma. Am J Otolaryngol 2012;33:6-13. [PMID: 21439681 DOI: 10.1016/j.amjoto.2010.11.018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 81 |
Bonavia R, Inda MM, Vandenberg S, Cheng SY, Nagane M, Hadwiger P, Tan P, Sah DW, Cavenee WK, Furnari FB. EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway. Oncogene 2012;31:4054-66. [PMID: 22139077 DOI: 10.1038/onc.2011.563] [Cited by in Crossref: 123] [Cited by in F6Publishing: 134] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 82 |
Fukuda K, Saikawa Y, Takahashi M, Takahashi T, Wada N, Kawakubo H, Takeuchi H, Kitagawa Y. Antitumor effect of cetuximab in combination with S-1 in EGFR-amplified gastric cancer cells. Int J Oncol 2012;40:975-82. [PMID: 22139134 DOI: 10.3892/ijo.2011.1279] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 83 |
Patel SP, Kim KB, Papadopoulos NE, Hwu WJ, Hwu P, Prieto VG, Bar-Eli M, Zigler M, Dobroff A, Bronstein Y, Bassett RL, Vardeleon AG, Bedikian AY. A phase II study of gefitinib in patients with metastatic melanoma. Melanoma Res 2011;21:357-63. [PMID: 21738104 DOI: 10.1097/CMR.0b013e3283471073] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 84 |
Wang P, Wang X, Wu P, Zhang J, Sato T, Yamagata S, Yamagata T. GM3 Upregulation of matrix metalloproteinase-9 possibly through PI3K, AKT, RICTOR, RHOGDI-2, and TNF-A pathways in mouse melanoma B16 cells. Adv Exp Med Biol 2011;705:335-48. [PMID: 21618116 DOI: 10.1007/978-1-4419-7877-6_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 85 |
Argiris A, Duffy AG, Kummar S, Simone NL, Arai Y, Kim SW, Rudy SF, Kannabiran VR, Yang X, Jang M, Chen Z, Suksta N, Cooley-Zgela T, Ramanand SG, Ahsan A, Nyati MK, Wright JJ, Van Waes C. Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer. Clin Cancer Res 2011;17:5755-64. [PMID: 21750205 DOI: 10.1158/1078-0432.CCR-11-0861] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 86 |
Lee SC, Ferris RL. Immunology of Head and Neck Cancer. Head and Neck Cancer 2011. [DOI: 10.1007/978-1-4419-9464-6_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 87 |
Duffey D, Dolgilevich S, Razzouk S, Li L, Green R, Gorti GK. Activating transcription factor-2 in survival mechanisms in head and neck carcinoma cells. Head Neck 2011;33:1586-99. [PMID: 21990224 DOI: 10.1002/hed.21648] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 88 |
Sen T, Chatterjee A. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process. Eur J Nutr 2011;50:465-78. [PMID: 21170718 DOI: 10.1007/s00394-010-0158-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 89 |
Okera M, Bae K, Bernstein E, Cheng L, Lawton C, Wolkov H, Pollack A, Dicker A, Sandler H, Sweeney CJ. Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610. BJU Int 2011;108:E51-8. [PMID: 21156016 DOI: 10.1111/j.1464-410X.2010.09884.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 90 |
Bito T, Sumita N, Ashida M, Budiyanto A, Ueda M, Ichihashi M, Tokura Y, Nishigori C. Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt Signaling Suppresses Cell Proliferation and Survival through Regulation of Stat3 Activation in Human Cutaneous Squamous Cell Carcinoma. J Skin Cancer 2011;2011:874571. [PMID: 21197106 DOI: 10.1155/2011/874571] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 91 |
Luangdilok S, Box C, Harrington K, Rhŷs-Evans P, Eccles S. MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. Eur J Cancer 2011;47:520-9. [PMID: 21074412 DOI: 10.1016/j.ejca.2010.10.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 92 |
Dilly M, Hambruch N, Haeger JD, Pfarrer C. Epidermal growth factor (EGF) induces motility and upregulates MMP-9 and TIMP-1 in bovine trophoblast cells. Mol Reprod Dev 2010;77:622-9. [PMID: 20578063 DOI: 10.1002/mrd.21197] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 93 |
Ivison SM, Khan MA, Graham NR, Shobab LA, Yao Y, Kifayet A, Sly LM, Steiner TS. The p110α and p110β isoforms of class I phosphatidylinositol 3-kinase are involved in toll-like receptor 5 signaling in epithelial cells. Mediators Inflamm 2010;2010:652098. [PMID: 20953381 DOI: 10.1155/2010/652098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 94 |
Shih YP, Liao YC, Lin Y, Lo SH. DLC1 negatively regulates angiogenesis in a paracrine fashion. Cancer Res 2010;70:8270-5. [PMID: 20861185 DOI: 10.1158/0008-5472.CAN-10-1174] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 95 |
Ehsanian R, Brown M, Lu H, Yang XP, Pattatheyil A, Yan B, Duggal P, Chuang R, Doondeea J, Feller S, Sudol M, Chen Z, Van Waes C. YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets. Oncogene 2010;29:6160-71. [PMID: 20729916 DOI: 10.1038/onc.2010.339] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 96 |
Dong GW, DO NY, Lim SC. Relation between proinflammatory mediators and epithelial-mesenchymal transition in head and neck squamous cell carcinoma. Exp Ther Med 2010;1:885-91. [PMID: 22993614 DOI: 10.3892/etm.2010.124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 97 |
Mishra A, Bharti AC, Saluja D, Das BC. Transactivation and expression patterns of Jun and Fos/AP-1 super-family proteins in human oral cancer. Int J Cancer 2010;126:819-29. [PMID: 19653276 DOI: 10.1002/ijc.24807] [Cited by in Crossref: 16] [Cited by in F6Publishing: 36] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 98 |
Pathi SP, Kowalczewski C, Tadipatri R, Fischbach C. A novel 3-D mineralized tumor model to study breast cancer bone metastasis. PLoS One 2010;5:e8849. [PMID: 20107512 DOI: 10.1371/journal.pone.0008849] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 99 |
Krause M, Gurtner K, Deuse Y, Baumann M. Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: Differences between antibodies and TK inhibitors. International Journal of Radiation Biology 2009;85:943-54. [DOI: 10.3109/09553000903232835] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 100 |
Van Waes C, Allen CT, Citrin D, Gius D, Colevas AD, Harold NA, Rudy S, Nottingham L, Muir C, Chen Z, Singh AK, Dancey J, Morris JC. Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010;77:447-54. [PMID: 19879702 DOI: 10.1016/j.ijrobp.2009.05.037] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 101 |
St John MA, Dohadwala M, Luo J, Wang G, Lee G, Shih H, Heinrich E, Krysan K, Walser T, Hazra S, Zhu L, Lai C, Abemayor E, Fishbein M, Elashoff DA, Sharma S, Dubinett SM. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res 2009;15:6018-27. [PMID: 19789323 DOI: 10.1158/1078-0432.CCR-09-0011] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 102 |
Lee KH, Kim JR. Hepatocyte growth factor induced up-regulations of VEGF through Egr-1 in hepatocellular carcinoma cells. Clin Exp Metastasis. 2009;26:685-692. [PMID: 19526316 DOI: 10.1007/s10585-009-9266-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 103 |
Yin Y, Wang S, Sun Y, Matt Y, Colburn NH, Shu Y, Han X. JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells. Biomed Pharmacother 2009;63:429-35. [PMID: 19553068 DOI: 10.1016/j.biopha.2009.04.045] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 104 |
Gan HK, Lappas M, Cao DX, Cvrljevdic A, Scott AM, Johns TG. Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalization. J Cell Mol Med 2009;13:3993-4001. [PMID: 19432811 DOI: 10.1111/j.1582-4934.2009.00783.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 105 |
Cohen J, Chen Z, Lu SL, Yang XP, Arun P, Ehsanian R, Brown MS, Lu H, Yan B, Diallo O, Wang XJ, Van Waes C. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer. Cancer Res 2009;69:3415-24. [PMID: 19351843 DOI: 10.1158/0008-5472.CAN-08-3704] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 106 |
Pernas FG, Allen CT, Winters ME, Yan B, Friedman J, Dabir B, Saigal K, Mundinger GS, Xu X, Morris JC, Calvo KR, Van Waes C, Chen Z. Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer. Clin Cancer Res 2009;15:2361-72. [PMID: 19318490 DOI: 10.1158/1078-0432.CCR-08-1011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 107 |
Kim S, Baker CH, Kitadai Y, Nakamura T, Kuwai T, Sasaki T, Langley R, Fidler IJ. The pathogenesis of cancer metastasis: relevance to therapy. Principles of Cancer Biotherapy 2009. [DOI: 10.1007/978-90-481-2289-9_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 108 |
Chen Z, Ehsanian R, Van Waes C. Nuclear Transcription Factors and Signaling Pathways in Oral Cancer Metastasis. Oral Cancer Metastasis 2009. [DOI: 10.1007/978-1-4419-0775-2_10] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 109 |
Brown M, Cohen J, Arun P, Chen Z, Van Waes C. NF-kappaB in carcinoma therapy and prevention. Expert Opin Ther Targets 2008;12:1109-22. [PMID: 18694378 DOI: 10.1517/14728222.12.9.1109] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 110 |
Chen Z, Ricker JL, Malhotra PS, Nottingham L, Bagain L, Lee TL, Yeh NT, Van Waes C. Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms. Mol Cancer Ther 2008;7:1949-60. [PMID: 18645005 DOI: 10.1158/1535-7163.MCT-07-2046] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 111 |
Saeed MF, Kolokoltsov AA, Freiberg AN, Holbrook MR, Davey RA. Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog 2008;4:e1000141. [PMID: 18769720 DOI: 10.1371/journal.ppat.1000141] [Cited by in Crossref: 144] [Cited by in F6Publishing: 148] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 112 |
Chen Z, Yan B, Van Waes C. The Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas. Biomark Med 2008;2:409-26. [PMID: 19444329 DOI: 10.2217/17520363.2.4.409] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 113 |
Smalley KS, Flaherty KT. Targeting BRAF Activity as a NovelParadigm for Melanoma Therapy. Melanoma: Translational Research and Emerging Therapies 2008. [DOI: 10.3109/9781420020328.006] [Reference Citation Analysis]
|
| 114 |
Chen SY, Takeuchi S, Moroi Y, Hayashida S, Kido M, Chen SJ, Tomoeda H, Uenotsuchi T, Tu YT, Furue M, Urabe K. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma. J Dermatol Sci 2008;51:210-5. [PMID: 18547788 DOI: 10.1016/j.jdermsci.2008.04.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 115 |
Borrello MG, Degl'Innocenti D, Pierotti MA. Inflammation and cancer: the oncogene-driven connection. Cancer Lett 2008;267:262-70. [PMID: 18502035 DOI: 10.1016/j.canlet.2008.03.060] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 116 |
Li J, Zhang D, Stoner GD, Huang C. Differential effects of black raspberry and strawberry extracts on BaPDE-induced activation of transcription factors and their target genes. Mol Carcinog 2008;47:286-94. [PMID: 18085529 DOI: 10.1002/mc.20377] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 117 |
Iwase M, Takaoka S, Uchida M, Yoshiba S, Kondo G, Watanabe H, Ohashi M, Nagumo M. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells. Oral Oncology 2008;44:361-8. [DOI: 10.1016/j.oraloncology.2007.04.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 118 |
Hasina R, Whipple ME, Martin LE, Kuo WP, Ohno-Machado L, Lingen MW. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications. Lab Invest 2008;88:342-53. [PMID: 18283272 DOI: 10.1038/labinvest.2008.6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 119 |
Bhat TA, Singh RP. Tumor angiogenesis – A potential target in cancer chemoprevention. Food and Chemical Toxicology 2008;46:1334-45. [DOI: 10.1016/j.fct.2007.08.032] [Cited by in Crossref: 109] [Cited by in F6Publishing: 100] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 120 |
Wang J, Seethala RR, Zhang Q, Gooding W, van Waes C, Hasegawa H, Ferris RL. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy. J Natl Cancer Inst 2008;100:502-12. [PMID: 18364504 DOI: 10.1093/jnci/djn059] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 121 |
Lee TL, Yeh J, Friedman J, Yan B, Yang X, Yeh NT, Van Waes C, Chen Z. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. Int J Cancer. 2008;122:1987-1998. [PMID: 18172861 DOI: 10.1002/ijc.23324] [Cited by in Crossref: 80] [Cited by in F6Publishing: 91] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 122 |
Yan B, Chen G, Saigal K, Yang X, Jensen ST, Van Waes C, Stoeckert CJ, Chen Z. Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status. Genome Biol 2008;9:R53. [PMID: 18334025 DOI: 10.1186/gb-2008-9-3-r53] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 123 |
Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, Travis WD, Bornmann W, Veach D, Clarkson B. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest. 2007;117:3846-3856. [PMID: 18060032 DOI: 10.1172/jci31871] [Cited by in Crossref: 492] [Cited by in F6Publishing: 520] [Article Influence: 32.8] [Reference Citation Analysis]
|
| 124 |
Allen CT, Ricker JL, Chen Z, Van Waes C. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Head Neck 2007;29:959-71. [PMID: 17405170 DOI: 10.1002/hed.20615] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 125 |
De Luca A, Carotenuto A, Rachiglio A, Gallo M, Maiello MR, Aldinucci D, Pinto A, Normanno N. The role of the EGFR signaling in tumor microenvironment. J Cell Physiol. 2008;214:559-567. [PMID: 17894407 DOI: 10.1002/jcp.21260] [Cited by in Crossref: 247] [Cited by in F6Publishing: 270] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 126 |
Patel BB, Majumdar APN. HER Family of Receptors as Treatment Targets in Pancreatic Cancer. Pancreatic Cancer 2008. [DOI: 10.1007/978-0-387-69252-4_36] [Reference Citation Analysis]
|
| 127 |
Allen GW, Harari PM. The Advancement of Epidermal Growth Factor Receptor Inhibitors in Cancer Therapy. Cancer Drug Discovery and Development. [DOI: 10.1007/978-1-59745-221-2_18] [Reference Citation Analysis]
|
| 128 |
Yan B, Yang X, Lee TL, Friedman J, Tang J, Van Waes C, Chen Z. Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma. Genome Biol 2007;8:R78. [PMID: 17498291 DOI: 10.1186/gb-2007-8-5-r78] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 129 |
Harari PM, Allen GW, Bonner JA. Biology of Interactions: Antiepidermal Growth Factor Receptor Agents. JCO 2007;25:4057-65. [DOI: 10.1200/jco.2007.11.8984] [Cited by in Crossref: 164] [Cited by in F6Publishing: 174] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 130 |
Agulnik M, da Cunha Santos G, Hedley D, Nicklee T, dos Reis PP, Ho J, Pond GR, Chen H, Chen S, Shyr Y, Winquist E, Soulieres D, Chen EX, Squire JA, Marrano P, Kamel-reid S, Dancey J, Siu LL, Tsao MS. Predictive and Pharmacodynamic Biomarker Studies in Tumor and Skin Tissue Samples of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Erlotinib. JCO 2007;25:2184-90. [DOI: 10.1200/jco.2006.07.6554] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 131 |
Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, Horwitz EM, Greenberg RE, Kolenko VM. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Prostate 2007;67:582-90. [PMID: 17262802 DOI: 10.1002/pros.20468] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 132 |
Hoff PM, Ellis LM. Targeted therapy trials: approval strategies, target validation, or helping patients? J Clin Oncol 2007;25:1639-41. [PMID: 17470854 DOI: 10.1200/JCO.2006.09.8384] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 133 |
Smalley KS, Herlyn M, Flaherty KT. Targeting BRAF/MEK in melanoma: new hope or another false dawn? Expert Review of Dermatology 2007;2:179-190. [DOI: 10.1586/17469872.2.2.179] [Reference Citation Analysis]
|
| 134 |
Phan LK, Hoff PM. Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: report of a case. Dis Colon Rectum 2007;50:395-8. [PMID: 17252287 DOI: 10.1007/s10350-006-0786-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 135 |
Hoy SM, Wagstaff AJ. Panitumumab: in the treatment of metastatic colorectal cancer. Drugs 2006;66:2005-14; discussion 2015-6. [PMID: 17100412 DOI: 10.2165/00003495-200666150-00011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 136 |
Zhu Z. CETUXIMAB (ERBITUX®), AN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER. Target Validation in Drug Discovery 2007. [DOI: 10.1016/b978-012369393-8/50004-3] [Reference Citation Analysis]
|
| 137 |
Mishra A, Bharti AC, Varghese P, Saluja D, Das BC. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection. Int J Cancer. 2006;119:2840-2850. [PMID: 16998793 DOI: 10.1002/ijc.22262] [Cited by in Crossref: 86] [Cited by in F6Publishing: 100] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 138 |
Heidemann J, Binion DG, Domschke W, Kucharzik T. Antiangiogenic therapy in human gastrointestinal malignancies. Gut 2006;55:1497-511. [PMID: 16966704 DOI: 10.1136/gut.2005.088229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 139 |
Yu M, Yeh J, Van Waes C. Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells. Cancer Res 2006;66:6722-31. [PMID: 16818647 DOI: 10.1158/0008-5472.CAN-05-3758] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 140 |
Jackson-bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-κB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 2007;26:1385-97. [DOI: 10.1038/sj.onc.1209945] [Cited by in Crossref: 150] [Cited by in F6Publishing: 155] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 141 |
Baker CH, Pino MS, Fidler IJ. Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells in human renal cell carcinoma is a primary target for therapy by tyrosine kinase inhibitors. Neoplasia 2006;8:470-6. [PMID: 16820093 DOI: 10.1593/neo.06172] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 142 |
Kudrin A, Scott M, Martin S, Chung CW, Donn R, McMaster A, Ellison S, Ray D, Ray K, Binks M. Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J Biol Chem 2006;281:29641-51. [PMID: 16893895 DOI: 10.1074/jbc.M601103200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 143 |
Brook NR, Colquhoun AJ, Mellon JK. Management of transitional cell carcinoma by targeting the epidermal growth factor receptor. Therapy 2006;3:407-416. [DOI: 10.2217/14750708.3.3.407] [Reference Citation Analysis]
|
| 144 |
Brook NR, Colquhoun AJ, Mellon JK. Management of transitional cell carcinoma by targeting the epidermal growth factor receptor. Therapy 2006;3:407-416. [DOI: 10.1586/14750708.3.3.407] [Reference Citation Analysis]
|
| 145 |
Howell GM, Grandis JR. Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck 2005;27:710-7. [PMID: 15952195 DOI: 10.1002/hed.20222] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 146 |
Kuwahara I, Lillehoj EP, Lu W, Singh IS, Isohama Y, Miyata T, Kim KC. Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-{kappa}B activation via EGFR transactivation in a lung epithelial cell line. Am J Physiol Lung Cell Mol Physiol 2006;291:L407-16. [PMID: 16632517 DOI: 10.1152/ajplung.00471.2005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 147 |
Burtness B. The role of cetuximab in the treatment of squamous cell cancer of the head and neck. Expert Opin Biol Ther. 2005;5:1085-1093. [PMID: 16050785 DOI: 10.1517/14712598.5.8.1085] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 148 |
Ding J, Li J, Chen J, Chen H, Ouyang W, Zhang R, Xue C, Zhang D, Amin S, Desai D, Huang C. Effects of polycyclic aromatic hydrocarbons (PAHs) on vascular endothelial growth factor induction through phosphatidylinositol 3-kinase/AP-1-dependent, HIF-1alpha-independent pathway. J Biol Chem 2006;281:9093-100. [PMID: 16461351 DOI: 10.1074/jbc.M510537200] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 149 |
Stoeltzing O, Ellis LM. Regulators of Vascular Endothelial Growth Factor Expression in Cancer. Molecular Targeting and Signal Transduction. [DOI: 10.1007/1-4020-7847-1_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 150 |
Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 2006;243:47-54. [PMID: 16387424 DOI: 10.1016/j.canlet.2005.11.019] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 151 |
Zhang H, Ma G, Dong M, Zhao M, Shen X, Ma Z, Guo K. Epidermal growth factor promotes invasiveness of pancreatic cancer cells through NF-kappaB-mediated proteinase productions. Pancreas 2006;32:101-9. [PMID: 16340751 DOI: 10.1097/01.mpa.0000191644.94301.be] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 152 |
Weylie B, Zhu J, Singh U, Ambrus S, Forough R. Phosphatidylinositide 3-Kinase Is Important in Late-Stage Fibroblast Growth Factor-1-Mediated Angiogenesis in vivo. J Vasc Res 2005;43:61-9. [DOI: 10.1159/000089492] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 153 |
Balin-Gauthier D, Delord JP, Rochaix P, Mallard V, Thomas F, Hennebelle I, Bugat R, Canal P, Allal C. In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR. Cancer Chemother Pharmacol. 2006;57:709-718. [PMID: 16320055 DOI: 10.1007/s00280-005-0123-3] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 154 |
Méndez-Samperio P, Trejo A, Miranda E. Mycobacterium bovis BCG induces CXC chemokine ligand 8 secretion via the MEK-dependent signal pathway in human epithelial cells. Cell Immunol 2005;234:9-15. [PMID: 15894298 DOI: 10.1016/j.cellimm.2005.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 155 |
Raspollini MR, Castiglione F, Garbini F, Villanucci A, Amunni G, Baroni G, Boddi V, Taddei GL. Correlation of epidermal growth factor receptor expression with tumor microdensity vessels and with vascular endothelial growth factor expression in ovarian carcinoma. Int J Surg Pathol 2005;13:135-42. [PMID: 15864375 DOI: 10.1177/106689690501300202] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 156 |
Morio A, Miyamoto H, Izumi H. Risk of recurrence after surgical resection of small-sized invasive lung adenocarcinoma: Analysis based on apoptotic index. Jpn J Thorac Cardiovasc Surg 2005;53:345-53. [DOI: 10.1007/s11748-005-0048-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 157 |
Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P, Eccles SA. Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev. 2005;24:47-69. [PMID: 15785872 DOI: 10.1007/s10555-005-5047-1] [Cited by in Crossref: 124] [Cited by in F6Publishing: 104] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 158 |
Schiffer E, Housset C, Cacheux W, Wendum D, Desbois-Mouthon C, Rey C, Clergue F, Poupon R, Barbu V, Rosmorduc O. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 2005;41:307-14. [PMID: 15660382 DOI: 10.1002/hep.20538] [Cited by in Crossref: 248] [Cited by in F6Publishing: 255] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 159 |
Wu JL, Abe T, Inoue R, Fujiki M, Kobayashi H. IkappaBalphaM suppresses angiogenesis and tumorigenesis promoted by a constitutively active mutant EGFR in human glioma cells. Neurol Res 2004;26:785-91. [PMID: 15494123 DOI: 10.1179/016164104225014139] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 160 |
Brown TT, Zelnik DL, Dobs AS. Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients. Int J Gastrointest Cancer. 2003;34:143-150. [PMID: 15361649 DOI: 10.1385/ijgc:] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
|
| 161 |
Camp ER, Summy J, Bauer TW, Liu W, Gallick GE, Ellis LM. Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor. Clinical Cancer Research 2005;11:397-405. [DOI: 10.1158/1078-0432.397.11.1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 162 |
Riedl K, Krysan K, Põld M, Dalwadi H, Heuze-Vourc'h N, Dohadwala M, Liu M, Cui X, Figlin R, Mao JT, Strieter R, Sharma S, Dubinett SM. Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist Updat 2004;7:169-84. [PMID: 15296859 DOI: 10.1016/j.drup.2004.04.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 163 |
Ellis LM. Epidermal growth factor receptor in tumor angiogenesis. Hematol Oncol Clin North Am. 2004;18:1007-1021, viii. [PMID: 15474332 DOI: 10.1016/j.hoc.2004.06.002] [Cited by in Crossref: 120] [Cited by in F6Publishing: 107] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 164 |
Yamauchi N, Harada T, Taniguchi F, Yoshida S, Iwabe T, Terakawa N. Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen-activated protein kinase pathways. Fertil Steril 2004;82 Suppl 3:1023-8. [PMID: 15474068 DOI: 10.1016/j.fertnstert.2004.02.134] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 165 |
Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer. 2004;111:679-692. [PMID: 15252836 DOI: 10.1002/ijc.20333] [Cited by in Crossref: 197] [Cited by in F6Publishing: 204] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 166 |
Hirata A, Uehara H, Izumi K, Naito S, Kuwano M, Ono M. Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839). Cancer Science 2004;95:614-8. [DOI: 10.1111/j.1349-7006.2004.tb02496.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 167 |
Rafiee P, Heidemann J, Ogawa H, Johnson NA, Fisher PJ, Li MS, Otterson MF, Johnson CP, Binion DG. Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling. Cell Commun Signal. 2004;2:3. [PMID: 15175101 DOI: 10.1186/1478-811x-2-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 168 |
Ma C, Wang J, Luo J. Activation of nuclear factor kappa B by diesel exhaust particles in mouse epidermal cells through phosphatidylinositol 3-kinase/Akt signaling pathway. Biochemical Pharmacology 2004;67:1975-83. [DOI: 10.1016/j.bcp.2004.01.023] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 169 |
Ellis LM, Hoff PM. Targeting the Epidermal Growth Factor Receptor: An Important Incremental Step in the Battle Against Colorectal Cancer. JCO 2004;22:1177-9. [DOI: 10.1200/jco.2004.01.971] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 170 |
Bachelor MA, Bowden G. UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression. Seminars in Cancer Biology 2004;14:131-8. [DOI: 10.1016/j.semcancer.2003.09.017] [Cited by in Crossref: 196] [Cited by in F6Publishing: 165] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 171 |
Singh AB, Tsukada T, Zent R, Harris RC. Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells. Journal of Cell Science 2004;117:1365-79. [DOI: 10.1242/jcs.01037] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 172 |
Sclabas GM, Fujioka S, Schmidt C, Evans DB, Chiao PJ. NF-kappaB in pancreatic cancer. Int J Gastrointest Cancer 2003;33:15-26. [PMID: 12909735 DOI: 10.1385/IJGC:33:1:15] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 173 |
Williams SA, Mcconkey DJ. Proteasome Inhibition and Apoptosis. Proteasome Inhibitors in Cancer Therapy 2004. [DOI: 10.1007/978-1-59259-794-9_7] [Reference Citation Analysis]
|
| 174 |
Stewart J, Siavash H, Hebert C, Norris K, Nikitakis N, Sauk J. Phenotypic switching of VEGF and collagen XVIII during hypoxia in head and neck squamous carcinoma cells. Oral Oncology 2003;39:862-9. [DOI: 10.1016/s1368-8375(03)00110-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 175 |
Wang B, Cleary PP, Xu H, Li JD. Up-regulation of interleukin-8 by novel small cytoplasmic molecules of nontypeable Haemophilus influenzae via p38 and extracellular signal-regulated kinase pathways. Infect Immun 2003;71:5523-30. [PMID: 14500470 DOI: 10.1128/IAI.71.10.5523-5530.2003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 176 |
Khuri FR. Primary and Secondary Prevention of Non–Small-Cell Lung Cancer: The SPORE Trials of Lung Cancer Prevention. Clinical Lung Cancer 2003;5:S36-40. [DOI: 10.3816/clc.2003.s.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 177 |
Magné N, Fischel JL, Tiffon C, Formento P, Dubreuil A, Renée N, Formento JL, Francoual M, Ciccolini J, Etienne MC, Milano G. Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin/5-fluorouracil. Br J Cancer 2003;89:585-92. [PMID: 12888834 DOI: 10.1038/sj.bjc.6601131] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 178 |
Glennie MJ, van de Winkel JG. Renaissance of cancer therapeutic antibodies. Drug Discov Today 2003;8:503-10. [PMID: 12818520 DOI: 10.1016/s1359-6446(03)02714-4] [Cited by in Crossref: 118] [Cited by in F6Publishing: 120] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 179 |
Korc M. Pathways for aberrant angiogenesis in pancreatic cancer. Mol Cancer 2003;2:8. [PMID: 12556241 DOI: 10.1186/1476-4598-2-8] [Cited by in Crossref: 138] [Cited by in F6Publishing: 144] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 180 |
Schechter NR, Yang DJ, Azhdarinia A, Kohanim S, Wendt R 3rd, Oh CS, Hu M, Yu DF, Bryant J, Ang KK, Forster KM, Kim EE, Podoloff DA. Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody. Anticancer Drugs 2003;14:49-56. [PMID: 12544258 DOI: 10.1097/00001813-200301000-00007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 181 |
Suh J, Rabson AB. NF-?B activation in human prostate cancer: Important mediator or epiphenomenon? J Cell Biochem 2004;91:100-17. [DOI: 10.1002/jcb.10729] [Cited by in Crossref: 173] [Cited by in F6Publishing: 181] [Article Influence: 8.7] [Reference Citation Analysis]
|
